New review elucidates potential contributors to non-alcoholic fatty liver disease
Tumors form temporary structures to avoid immunotherapy treatments
20 September 2022Take care when handling, storing your contact lenses
20 September 2022New review elucidates potential contributors to non-alcoholic fatty liver disease
The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most widespread disorders worldwide, is expected to rise by more than 50% by 2030. Non-alcoholic fatty liver (NAFL), the initial stage of NAFLD, is associated with fat accumulation and, sometimes, mild inflammation.
